Spirometry for the Diagnosis and Management of Chronic Obstructive Pulmonary Disease

被引:0
作者
MacIntyre, Neil R. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC USA
[2] Duke Univ, Med Ctr, Resp Care Serv, Durham, NC USA
关键词
spirometry; obstructive airway disease; screening tests; chronic obstructive pulmonary disease management; pulmonary function tests; perioperative risk assessment; SMOKING-CESSATION ADVICE; RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE SPIROMETRY; OFFICE SPIROMETRY; GENERAL-PRACTICE; LUNG-FUNCTION; NUTRITION EXAMINATION; AIRWAY-OBSTRUCTION; NATIONAL-HEALTH; COPD;
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Spirometric testing is one of the oldest clinical tests still in use today. It is a straightforward test that has the patient maximally exhale from total lung capacity. The key measurements are the forced expiratory volume in the first second (FEV1) and the maximum exhaled volume (vital capacity [VC]). Spirometric testing utility, however, depends heavily upon the quality of equipment, the patient cooperation, and the skill of the technician performing the test. Spirometry should thus be considered a medical test and not simply a vital sign that can be performed by minimally trained personnel. In obstructive lung diseases such as chronic obstructive pulmonary disease (COPD), the characteristic changes in spirometry are a reduction in the FEV1 with respect to the vital capacity (FEV1/VC ratio). Using this measurement can diagnose the presence and severity of airway obstruction. This can be used to guide therapies and predict outcomes. Using spirometry to screen for obstructive lung disease, however, can be problematic, and the effect of screening on outcomes has yet to be demonstrated.
引用
收藏
页码:1050 / 1057
页数:8
相关论文
共 58 条
[31]  
Hutchinson J, 1846, Med Chir Trans, V29, P137
[32]   Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease [J].
Incalzi, RA ;
Fuso, L ;
De Rosa, M ;
Forastiere, F ;
Rapiti, E ;
Nardecchia, B ;
Pistelli, R .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (12) :2794-2800
[33]  
KANNER R E, 1984, Chest, V85, p15S, DOI 10.1378/chest.85.6_Supplement.15S-a
[34]   PREDICTORS OF SURVIVAL IN SUBJECTS WITH CHRONIC AIR-FLOW LIMITATION [J].
KANNER, RE ;
RENZETTI, AD ;
STANISH, WM ;
BARKMAN, HW ;
KLAUBER, MR .
AMERICAN JOURNAL OF MEDICINE, 1983, 74 (02) :249-255
[35]   Effectiveness of interventions to help people stop smoking:: findings from the Cochrane Library [J].
Lancaster, T ;
Stead, L ;
Silagi, C ;
Sowden, A .
BRITISH MEDICAL JOURNAL, 2000, 321 (7257) :355-358
[36]   AN ANALYSIS OF THE EFFECTIVENESS OF INTERVENTIONS INTENDED TO HELP PEOPLE STOP SMOKING [J].
LAW, M ;
TANG, JL .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (18) :1933-1941
[37]   Spirometry use in clinical practice following diagnosis of COPD [J].
Lee, Todd A. ;
Bartle, Brian ;
Weiss, Kevin B. .
CHEST, 2006, 129 (06) :1509-1515
[38]   Screening for chronic obstructive pulmonary disease using spirometry: Summary of the evidence for the US preventive services task force [J].
Lin, Kenneth ;
Watkins, Bradley ;
Johnson, Tamara ;
Rodriguez, Joy Anne ;
Barton, Mary B. .
ANNALS OF INTERNAL MEDICINE, 2008, 148 (07) :535-543
[39]  
LUNN WW, 1995, OTOLARYNG CLIN N AM, V28, P721
[40]   A randomized controlled trial on office spirometry in asthma and COPD in standard general practice - Data from spirometry in asthma and COPD: a comparative evaluation Italian study [J].
Lusuardi, M ;
De Benedetto, F ;
Paggiaro, P ;
Sanguinetti, CM ;
Brazzola, G ;
Ferri, P ;
Donner, CF .
CHEST, 2006, 129 (04) :844-852